39.16

1.43% -0.57

After Hours: 39.16

Royalty Pharma Plc (RPRX)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Royalty Pharma Plc stock is traded at $39.16, with a volume of 2.57M. It is down -1.43% in the last 24 hours and up +8.78% over the past month. Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Previous Close:

$39.73

Open:

$39.42

24h Volume:

2.57M

Relative Volume:

0.63

Market Cap:

$16.93B

Revenue:

$2.31B

Net Income/Loss:

$1.66B

P/E Ratio:

17.05

EPS:

2.297

Net Cash Flow:

$827.02M

1W Performance:

+1.56%

1M Performance:

+8.78%

6M Performance:

+21.28%

1Y Performance:

+53.09%

1-Day Range:

$38.82

$39.65

1-Week Range:

$38.39

$40.01

52-Week Range:

$24.05

$41.24

Royalty Pharma Plc Stock (RPRX) Company Profile

Name

Royalty Pharma Plc

Sector

Healthcare (1135)

Industry

Biotechnology (634)

Phone

(212) 883-0200

Address

110 EAST 59TH STREET, NEW YORK, NY

Employee

Twitter

Next Earnings Date

2025-02-11

Latest SEC Filings

RPRX's Discussions on Twitter

Compare RPRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RPRX Royalty Pharma Plc	39.16	16.97B	2.31B	1.66B	827.02M	2.297
VRTX Vertex Pharmaceuticals Inc	437.15	110.25B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	693.50	73.04B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	449.16	59.98B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	907.98	54.90B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	193.22	40.73B	447.02M	-1.18B	-906.14M	-6.1812

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-25	Initiated	Goldman	Buy
May-16-25	Initiated	Morgan Stanley	Overweight
Jun-03-24	Downgrade	UBS	Buy → Neutral
Jun-14-22	Resumed	UBS	Buy
May-13-22	Initiated	Scotiabank	Sector Outperform
Apr-27-22	Initiated	Goldman	Buy
Apr-14-22	Upgrade	JP Morgan	Neutral → Overweight
Apr-06-22	Resumed	Morgan Stanley	Overweight
Oct-29-21	Upgrade	Citigroup	Neutral → Buy
Jul-30-21	Initiated	Tigress Financial	Buy
Nov-09-20	Upgrade	UBS	Neutral → Buy
Jul-14-20	Initiated	Evercore ISI	In-line
Jul-13-20	Initiated	BofA Securities	Buy
Jul-13-20	Initiated	Citigroup	Neutral
Jul-13-20	Initiated	Cowen	Outperform
Jul-13-20	Initiated	Goldman	Neutral
Jul-13-20	Initiated	JP Morgan	Neutral
Jul-13-20	Initiated	Morgan Stanley	Equal-Weight
Jul-13-20	Initiated	SunTrust	Buy
Jul-13-20	Initiated	UBS	Neutral

View All

Royalty Pharma Plc Stock (RPRX) Latest News

07:06 AM

Is Royalty Pharma plc (RPD) stock attractive post correctionJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com

07:06 AM

03:20 AM

What’s the recovery path for long term holders of Royalty Pharma plc - newser.com

03:20 AM

02:09 AM

Top chart patterns to watch in Royalty Pharma plcWeekly Investment Report & Verified Momentum Watchlists - newser.com

02:09 AM

01:23 AM

Analyzing net buyer seller activity in Royalty Pharma plcJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com

01:23 AM

05:23 AM

Can Royalty Pharma plc stock rebound after recent weaknessPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com

05:23 AM

03:21 AM

Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat

03:21 AM

01:22 AM

Will Royalty Pharma plc (RPD) stock hit Wall Street targetsAnalyst Downgrade & Free High Return Stock Watch Alerts - newser.com

01:22 AM

Nov 15, 2025

Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Rally & Free Safe Capital Growth Stock Tips - newser.com

Nov 15, 2025

Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com

Nov 15, 2025

Why analysts remain bullish on Royalty Pharma plc stockForecast Cut & AI Forecast Swing Trade Picks - newser.com

Nov 15, 2025

Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com

Nov 15, 2025

Applying chart zones and confluence areas to Royalty Pharma plcInsider Selling & Free Daily Entry Point Trade Alerts - newser.com

Nov 15, 2025

Quantitative breakdown of Royalty Pharma plc recent moveMarket Growth Report & Reliable Trade Execution Plans - newser.com

Nov 15, 2025

Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Nov 15, 2025

Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha

Nov 15, 2025

Historical volatility pattern of Royalty Pharma plc visualizedEarnings Recap Report & Daily Market Momentum Tracking - newser.com

Nov 15, 2025

Nov 14, 2025

Why retail investors pile into Royalty Pharma plc stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com

Nov 14, 2025

Is Royalty Pharma plc (RPD) stock a buy during volatile marketsVolume Spike & Verified Chart Pattern Signals - newser.com

Nov 14, 2025

Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025

What drives Royalty Pharma plc stock priceResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in

Nov 14, 2025

How Royalty Pharma plc (RPD) stock performs in easing cyclesEarnings Growth Report & Community Trade Idea Sharing - newser.com

Nov 14, 2025

Mitsubishi UFJ Trust & Banking Corp Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025

Nov 13, 2025

Will Royalty Pharma plc (RPD) stock maintain strong growthRisk Management & Weekly High Return Stock Opportunities - newser.com

Nov 13, 2025

Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Nov 13, 2025

Nov 12, 2025

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance

Nov 12, 2025

Is Royalty Pharma plc reversing from oversold territoryWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Nov 12, 2025

Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq

Nov 12, 2025

Bank of New York Mellon Corp Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Nov 12, 2025